1. Peripheral neuropathic pain
- Author
-
Denise Lester, Ellie Balakhanlou, F. Clay Smither, and Douglas P Murphy
- Subjects
medicine.medical_specialty ,Population ,Physical Therapy, Sports Therapy and Rehabilitation ,03 medical and health sciences ,0302 clinical medicine ,Quality of life ,medicine ,Back pain ,Humans ,030212 general & internal medicine ,education ,Intensive care medicine ,Burning Pain ,education.field_of_study ,business.industry ,Cannabinoids ,Rehabilitation ,Peripheral Nervous System Diseases ,Nerve Block ,medicine.disease ,Antidepressive Agents ,Analgesics, Opioid ,medicine.anatomical_structure ,Peripheral nervous system ,Hyperalgesia ,Neuropathic pain ,Quality of Life ,Transcutaneous Electric Nerve Stimulation ,Neuralgia ,Neurology (clinical) ,medicine.symptom ,business ,Polyneuropathy ,030217 neurology & neurosurgery - Abstract
Neuropathic pain (NP) can have either central nervous system causes or ones from the peripheral nervous system. This article will focus on the epidemiology, classifications, pathology, non-invasive treatments and invasive treatments as a general review of NP involving the peripheral nervous system. NP has characteristic symptomatology such as burning and electrical sensations. It occurs in up to 10% of the general population. Its frequency can be attributed to its occurrence in neck and back pain, diabetes and patients receiving chemotherapy. There are a wide range of pharmacologic options to control this type of pain and when such measures fail, numerous interventional methods can be employed such as nerve blocks and implanted stimulators. NP has a cost to the patient and society in terms of emotional consequences, quality of life, lost wages and the cost of assistance from the medical system and thus deserves serious consideration for prevention, treatment and control.
- Published
- 2020